Neurogene
Stock Forecast, Prediction & Price Target
Neurogene (NGNE) stock Price Target by analysts
$52.75
Potential upside: 167.76%
Neurogene price prediction
What is Neurogene stock analysts` prediction?
Neurogene stock forecast: Based on 2 Wall Street analysts` predicted price targets for Neurogene in the last 3 months, the avarage price target is $52.75, with a high forecast of $NaN. The average price target represents a 167.76% change from the last price of $19.7.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Neurogene stock Price Target by analysts
Full breakdown of analysts given Neurogene price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Paul Matteis Stifel Nicolaus | 0% 0/2 | 10 months ago | $46 133.50% upside | $15.33 | StreetInsider | Previous targets (1) |
Keith Tapper BMO Capital | 0% 0/3 | 10 months ago | $45 128.42% upside | $35.59 | StreetInsider | Previous targets (2) |
Paul Matteis Stifel Nicolaus | 0% 0/2 | 10 months ago | $60 204.56% upside | $64.48 | StreetInsider | Previous targets (1) |
Keith Tapper BMO Capital | 0% 0/3 | 10 months ago | $60 204.56% upside | $64.48 | StreetInsider | Previous targets (2) |
Mitchell Kapoor H.C. Wainwright | 0% 0/1 | about 1 year ago | $49 148.73% upside | $35.59 | TheFly | Previous targets (0) |
Keith Tapper BMO Capital | 0% 0/3 | about 1 year ago | $65 229.94% upside | $32.01 | StreetInsider | Previous targets (2) |
Joel Beatty Robert W. Baird | 0% 0/1 | about 1 year ago | $54 174.11% upside | $37.35 | StreetInsider | Previous targets (0) |
Mitchel Kapoor H.C. Wainwright | 0% 0/1 | over 1 year ago | $51 158.88% upside | $30.26 | StreetInsider | Previous targets (0) |
Neurogene Financial Estimates
Neurogene Revenue Estimates
Neurogene EBITDA Estimates
Neurogene Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $38.30M Low: $38.30M High: $38.30M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $33M Low: $33M High: $33M avg. 0% |
Net Income
% change YoY
| $-50.51M N/A | $-55.18M -9.24% | $-36.31M 34.19% | Avg: $-85.97M Low: $-70.40M High: $-29.49M avg. -136.72% | Avg: $-103.36M Low: $-74.24M High: $-54.11M avg. -20.23% | Avg: $-64.63M Low: $-64.63M High: $-64.63M avg. 37.47% | Avg: $-62.23M Low: $-62.23M High: $-62.23M avg. 3.70% |
EBITDA
% change YoY
| $-49.57M N/A | $-51.98M -4.87% | $-52.28M -0.57% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.92 N/A | -$4.3 -367.39% | -$2.83 34.18% | Avg: -$4.17 Low: -$5.49 High: -$2.3 avg. -47.40% | Avg: -$4.97 Low: -$5.79 High: -$4.22 avg. -19.20% | Avg: -$5.04 Low: -$5.04 High: -$5.04 avg. -1.35% | Avg: -$4.85 Low: -$4.85 High: -$4.85 avg. 3.70% |
Operating Expenses
% change YoY
| $50.53M N/A | $56.51M 11.83% | $55.58M -1.65% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Neurogene stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -28.94% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -70.40M, average is -85.97M and high is -29.49M.
What is Neurogene stock revenue growth forecast?
We have gathered data from 6 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Neurogene stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -16.06% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$5.49, average is -$4.17 and high is $-2.3.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Neurogene stock. The most successful analyst is Paul Matteis.